Press Release Outlook Therapeutics Announces Pricing of $55.0 Million Public Offering of Common Stock and Warrants 3 hours ago
Press Release Outlook Therapeutics Announces Proposed Public Offering of Common Stock and Warrants 9 hours ago
Press Release Outlook Therapeutics to Report Third Quarter Fiscal Year 2026 Financial Results and Host a Corporate Update Conference Call and Webcast on August 14, 2026 Aug 6